Overview
Amana Takaful Life is a specialised Sri Lankan life insurer operating under the Takaful model, selling protection, savings, health and retirement products while earning investment and fund-management income. The latest reported quarter showed continued revenue expansion but lower operating and net profitability, so the central issue is converting growth in premiums and related income into durable profit.
Price performance
ATLL closed at LKR 18.50 on 3 November 2026. It had fallen 60.6% over one year against an 11.8% fall in the ASPI, a much steeper decline than the wider market over the same period.
The share sat near the bottom of its 52-week range. Its three-year record includes two falls of 15% or more, with the deepest decline 73.1% and still unrecovered. Liquidity is a major practical constraint: a LKR 1 million order is more than everything that trades on a typical day, at 1,622% of median daily turnover.
Valuation
ATLL is in the moderately overvalued market-wide band, scoring 21 of 100 on price against filed book value, earnings and dividends. Its P/B is 1.41 times, meaning the market price is LKR 1.41 for each LKR 1 of net assets, only slightly above the insurance-sector median of 1.36 times. The company is loss-making on the page's trailing EPS measure, so the headline P/E is not meaningful.
The available long-run own-history P/B comparison does not reconcile to the page measure, and there is no consecutive four-quarter earnings record for a comparable own-history P/E. On the trailing filed EPS calculation, the latest June quarter supplied 20.1% of trailing earnings; its P/E is 46.6 times, versus 39.1 times if that quarter had retained its year-ago net margin. The earnings represented by the current price therefore rely on a low-margin quarter rather than an improving margin.
News and sentiment
Direct company coverage is thin. The 90-day news set contains two material articles, both positive in tone, but there are no recent material company-specific reports to explain the share's three-month decline.
No dividend is on record in the last two years, and no confirmed or pending corporate action is listed.
Financials
In the June 2026 quarter, revenue grew 14.3% year-on-year while net profit fell 41.4%, so the additional income produced less profit for the shares. Gross margin is unavailable from the insurer's reported format. Operating margin narrowed from 1.7% to 1.5%, while net margin fell from 1.3% to 0.7%; both margins rank third of seven comparable June quarters, making the result middling against the company's own June record rather than an historic extreme.
Below-the-line items took LKR 4.6 million from operating profit, more than double the prior June drag. Equity increased year-on-year to LKR 656 million, while the ordinary share count remained unchanged at 50 million, so the weaker quarterly EPS reflects lower profit rather than a mechanical dilution of each share's claim.
Risks
The main financial risk is the insurer's high balance-sheet leverage: total liabilities, including policyholder obligations, were 7.99 times equity at the latest audited year-end, up from 6.82 times a year earlier. That leaves a relatively small equity buffer against movements in asset values or insurance liabilities. Borrowings were LKR 161.8 million at that point.
Profitability is also fragile, with June net margin only 0.7% and finance costs, tax and other below-the-line items taking more than half of operating profit. As at 3 November 2026, the insurance-sector backdrop included higher bond yields and rupee weakness, which can affect fixed-income portfolio valuations and foreign-currency reinsurance costs. The exceptionally low trading turnover adds a separate liquidity risk for any sizeable position.
Outlook
As at 3 November 2026, the next concrete event is the September 2026 interim filing, which is due now and was expected between 2 and 14 November. It will supersede the June figures and show whether revenue growth is beginning to flow through to profit or whether the low-margin outcome persisted.
The available data cannot establish how changes in bond yields, currency conditions or insurance claims will affect the next quarter. There are no scheduled dividends or corporate actions to provide a separate near-term company catalyst.